Partnership between small biotech and big pharma.

Margaret S Beer , Raymond G Hill , Gregory J Wiederrecht
IDrugs : the investigational drugs journal 9 ( 8) 560 -564

1
2006
CGRP receptors: a headache to study, but will antagonists prove therapeutic in migraine?

Susan D Brain , David R Poyner , Raymond G Hill
Trends in Pharmacological Sciences 23 ( 2) 51 -53

39
2002
Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries

Lars Edvinsson , Anette Sams , Inger Jansen-Olesen , Janos Tajti
European Journal of Pharmacology 415 ( 1) 39 -44

73
2001
The effect of adrenergic compounds on neurogenic dural vasodilatation

Simon Akerman , David J Williamson , Raymond G Hill , Peter J Goadsby
European Journal of Pharmacology 424 ( 1) 53 -58

35
2001
Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324

Tony Priestley , Petra Laughton , Alison J Macaulay , Raymond G Hill
Neuropharmacology 35 ( 11) 1573 -1581

32
1996
Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats

Michael J Cumberbatch , Emma Carlson , Andrea Wyatt , Susan Boyce
Neuropharmacology 37 ( 12) 1535 -1543

61
1998
Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils

Nadia M.J Rupniak , Emma Carlson , Susan Boyce , Janine K Webb
Pain 67 ( 1) 189 -195

82
1996
The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.

Michael J Cumberbatch , Raymond G Hill , Richard J Hargreaves
European Journal of Pharmacology 362 ( 1) 43 -46

58
1998
The anti-migraine 5-HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs

David J Williamson , Raymond G Hill , Sara L Shepheard , Richard J Hargreaves
British Journal of Pharmacology 133 ( 7) 1029 -1034

60
2001
Rizatriptan has central antinociceptive effects against durally evoked responses.

Michael J Cumberbatch , Raymond G Hill , Richard J Hargreaves
European Journal of Pharmacology 328 ( 1) 37 -40

137
1997
Novel strategies for pharmacotherapy of depression.

Karen A Maubach , Nadia MJ Rupniak , Mark S Kramer , Raymond G Hill
Current Opinion in Chemical Biology 3 ( 4) 481 -488

79
1999
The bradykinin B1 receptor antagonist B9858 inhibits a nociceptive spinal reflex in rabbits

Glenn S Mason , Michael J Cumberbatch , Raymond G Hill , Nadia MJ Rupniak
Canadian Journal of Physiology and Pharmacology 80 ( 4) 264 -268

32
2002
Regional and cellular localization of calcitonin gene-related peptide-receptor component protein mRNA in the guinea-pig central nervous system

Kevin R Oliver , Anna Wainwright , Anna M Kinsey , Robert P Heavens
Molecular Brain Research 66 ( 1) 205 -210

16
1999
Distribution of novel CGRP1 receptor and adrenomedullin receptor mRNAs in the rat central nervous system

Kevin R Oliver , Anna Wainwright , Robert P Heavens , Raymond G Hill
Molecular Brain Research 57 ( 1) 149 -154

67
1998
Nmda Antagonists As Potential Analgesic Drugs

Dalip J.S. Sirinathsinghji , Raymond G Hill , Ray G. Hill
Smpte Journal

2002
new developments in

Susan Boyce , Zahid Ali , Raymond G Hill ,
Drug Discovery 31 -31

2001
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

Mark S Kramer , Neal Cutler , John Feighner , Ram Shrivastava
Science 281 ( 5383) 1640 -1645

1,329
1998
Actions of microiontophoretically applied oxytocin, and immunohistochemical localization of oxytocin, vasopressin and neurophysin in the rat caudal medulla.

Richard Morris , Thomas E Salt , Michael V Sofroniew , Raymond G Hill
Neuroscience Letters 18 ( 2) 163 -168

68
1980